Business Description
BioLight Life Sciences Ltd
ISIN : IL0010952237
Total Employee Number:
4Description
BioLight Life Sciences Ltd is an emerging ophthalmic company. It is engaged in the discovery, development, and commercialization of products and product candidates which address ophthalmic conditions, including glaucoma, dry eye syndrome and age-related macular degeneration. The firm's products include ioptimate, eye-d technology, and diagnostear. The company has the Eye cluster and the Cancer diagnostics cluster operating segments. It derives the majority of its revenues from the Eye cluster segment.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 30.64 | |||||
Equity-to-Asset | 0.81 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.05 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -16 | |||||
3-Year EPS without NRI Growth Rate | 5.4 | |||||
3-Year FCF Growth Rate | 4.4 | |||||
3-Year Book Growth Rate | -31.1 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 42 | |||||
9-Day RSI | 43.8 | |||||
14-Day RSI | 47.31 | |||||
3-1 Month Momentum % | 69.67 | |||||
6-1 Month Momentum % | 10.23 | |||||
12-1 Month Momentum % | -25.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 12.19 | |||||
Quick Ratio | 12.19 | |||||
Cash Ratio | 11.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -25.5 | |||||
Shareholder Yield % | -58.62 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -42.98 | |||||
ROA % | -34.09 | |||||
ROIC % | -76.01 | |||||
3-Year ROIIC % | 22.95 | |||||
ROC (Joel Greenblatt) % | -394.84 | |||||
ROCE % | -51.94 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 0.97 | |||||
Price-to-Tangible-Book | 0.99 | |||||
EV-to-EBIT | -0.91 | |||||
EV-to-EBITDA | -0.94 | |||||
EV-to-Forward-Revenue | 18.39 | |||||
EV-to-FCF | -1.41 | |||||
| Price-to-Net-Current-Asset-Value | 2.04 | |||||
| Price-to-Net-Cash | 2.14 | |||||
Earnings Yield (Greenblatt) % | -109.89 | |||||
FCF Yield % | -32.39 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BioLight Life Sciences Ltd Executives
DetailsGF Value™
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚Ş) | |||
| EPS (TTM) (â‚Ş) | -1.98 | ||
| Beta | 0.0095 | ||
| 3-Year Sharpe Ratio | -0.1 | ||
| 3-Year Sortino Ratio | -0.15 | ||
| Volatility % | 38.27 | ||
| 14-Day RSI | 47.31 | ||
| 14-Day ATR (â‚Ş) | 0.254937 | ||
| 20-Day SMA (â‚Ş) | 3.8896 | ||
| 12-1 Month Momentum % | -25.1 | ||
| 52-Week Range (â‚Ş) | 2.092 - 5.433 | ||
| Shares Outstanding (Mil) | 9.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioLight Life Sciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioLight Life Sciences Ltd Stock Events
| Event | Date | Price (â‚Ş) | ||
|---|---|---|---|---|
| 0.04:1 Stock Split | 2016-02-28 | 24.35 (-1.18%) | ||
| 0.1:1 Stock Split | 2015-08-02 | 42.51 (-1.68%) |
Show
Entries
BioLight Life Sciences Ltd Frequently Asked Questions
What is BioLight Life Sciences Ltd(XTAE:BOLT)'s stock price today?
The current price of XTAE:BOLT is â‚Ş3.71. The 52 week high of XTAE:BOLT is â‚Ş5.43 and 52 week low is â‚Ş2.09.
When is next earnings date of BioLight Life Sciences Ltd(XTAE:BOLT)?
The next earnings date of BioLight Life Sciences Ltd(XTAE:BOLT) is .
Does BioLight Life Sciences Ltd(XTAE:BOLT) pay dividends? If so, how much?
BioLight Life Sciences Ltd(XTAE:BOLT) does not pay dividend.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Diagnostear, a subsidiary of BioLight Life Sciences Ltd, signed a binding Letter of Intent for merger, capital raise and listing on the Canadian Securities Exchange | 2023-06-12 |
Articles on BioLight Life Sciences Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers